The University of Vermont attained R1 status in February 2025, placing it in the top tier of research universities in the U.S. The university’s research profile in fiscal year 2024 attracted over $260 million in extramural support —more than doubling the university’s annual research funding in the last five years—and was led by the Larner College of Medicine which garnered over $100 million for biomedical, scientific and health related research. Scientific investigations at Larner resulted in improved treatments for sick infants and people with cancer, increased understanding of cardiovascular diseases and their impacts on dementia, new vaccines to combat infectious illnesses including Lyme disease, polio, the contagious respiratory virus RSV, and more.
Larner Research Highlights
Research at the Larner College of Medicine improves health outcomes, transforms lives, and addresses global health challenges. We share the stories of the questions, people, and innovations that are shaping a better, safer Vermont and planet.
